PAUSHAK LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,070 INR | +0.02% |
|
+1.05% | -16.45% |
| Sales 2022 | 1.5B 18.03M | Sales 2023 | 2.12B 25.5M | Capitalization | 19.16B 230M |
|---|---|---|---|---|---|
| Net income 2022 | 376M 4.52M | Net income 2023 | 540M 6.49M | EV / Sales 2022 | 21.1 x |
| Net cash position 2022 | 428M 5.14M | Net cash position 2023 | 706M 8.47M | EV / Sales 2023 | 8.69 x |
| P/E ratio 2022 |
85.2
x | P/E ratio 2023 |
35.5
x | Employees | 335 |
| Yield 2022 |
0.12% | Yield 2023 |
0.28% | Free-Float | 28.92% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.02% | ||
| 1 week | +1.05% | ||
| Current month | -0.56% | ||
| 1 month | +9.74% | ||
| 3 months | -8.09% | ||
| 6 months | -17.90% | ||
| Current year | -16.45% |
1 week
4 850.90
5 170.45
1 month
4 464.005 555.00
Current year
4 464.006 230.00
1 year
4 464.007 685.00
3 years
4 464.0012 400.00
5 years
1 301.8012 400.00
10 years
125.0012 400.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 13-04-30 | |
Kirti Shah
DFI | Director of Finance/CFO | - | 19-11-11 |
Chintan Gosaliya
COO | Chief Operating Officer | - | Nov. 01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 05-08-17 | |
| Director/Board Member | 44 | 06-08-17 | |
| Director/Board Member | 71 | 23-07-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 5,070 | +0.02% | 1 116 |
| 24-04-22 | 5,069 | +1.81% | 1,395 |
| 24-04-19 | 4,979 | -0.94% | 1,267 |
| 24-04-18 | 5,026 | +0.17% | 1,222 |
| 24-04-16 | 5,017 | -2.30% | 2,316 |
Delayed Quote Bombay S.E., April 23, 2024 at 04:46 am EDT
More quotes
Paushak Limited is an India-based company, which is engaged in the business of specialty chemicals. The Company is engaged in the business of manufacturing phosgene-based specialty chemicals. The Company serves various industries, such as pharmaceuticals, agrochemicals, performance and custom synthesis. Its product categories include chloroformate, isocyanate, chloride, carbonate/carbamate and others. Its chloroformate products include benzyl chloroformate, ethyl chloroformate, methyl chloroformate and myristyl chloroformate. The Company's isocyanate products include 2-chloro ethyl isocyanate, phenyl isocyanate and stearyl isocyanate. Its chloride products include 3 chloropropionyl chloride, diethyl carbamoyl chloride and dimethyl carbamoyl chloride. The Company's carbonate/carbamate products include polyquaternium, chloromethyl isopropyl carbonate and bis-(4 nitrophenyl) carbonate. Its other products include tetrabutyl urea, vilsmeier reagent and dicyclohexyl carbodiimide.
Sector
Specialty Chemicals
Calendar
2024-05-05
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -16.45% | 187M | |
| +10.57% | 62.7B | |
| -5.92% | 45.31B | |
| +12.92% | 39.92B | |
| +17.59% | 26.04B | |
| +3.16% | 17.99B | |
| -0.28% | 17.29B | |
| +5.08% | 15.65B | |
| -22.84% | 15.56B | |
| -22.28% | 13.2B |
- Stock Market
- Equities
- PAUSHAKLTD6 Stock
